Related Experiment Video
Updated: Jun 23, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
5-HT(1A) receptor function in major depressive disorder.
Jonathan Savitz1, Irwin Lucki, Wayne C Drevets
1Section on Neuroimaging in Mood and Anxiety Disorders, Mood and Anxiety Disorders Program, NIH/NIMH, Bethesda, MD 20892, United States. savitzj@mail.nih.gov
Progress in Neurobiology
|May 12, 2009
Summary
Serotonin 1A receptor (5-HT(1A)) dysfunction is linked to major depressive disorder (MDD). Evidence from pharmacology, post-mortem studies, PET scans, and genetics supports this, suggesting it
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Major depressive disorder (MDD) is a prevalent mental health condition with complex underlying mechanisms.
- The serotonin 1A receptor (5-HT(1A)) is implicated in mood regulation and stress response pathways.
Purpose of the Study:
- To review and synthesize evidence linking 5-HT(1A) receptor dysfunction to the development of major depressive disorder (MDD).
- To explore the role of 5-HT(1A) receptor dysfunction in MDD-associated cognitive impairment and somatic pain.
Main Methods:
- Review of pharmacological challenge studies using 5-HT(1A) receptor agonists.
- Analysis of post-mortem brain tissue studies examining 5-HT(1A) receptor expression and affinity.
- Examination of positron emission tomography (PET) studies assessing 5-HT(1A) receptor binding potential.
- Review of genetic studies investigating single nucleotide polymorphisms (SNPs) in the HTR1A gene.
Main Results:
- Pharmacological studies show blunted endocrine responses to 5-HT(1A) agonists in depressed patients.
- Treatments for MDD, including SSRIs, TCAs, and ECT, enhance postsynaptic 5-HT(1A) receptor signaling.
- Post-mortem and PET studies reveal reduced 5-HT(1A) receptor binding in key brain regions (dorsal raphe, mPFC, amygdala, hippocampus).
- 5-HT(1A) receptor knockout mice exhibit anxiety-like behaviors unresponsive to antidepressant treatment.
- The G allele of HTR1A SNP rs6295 is over-represented in MDD, while the C allele is linked to better antidepressant response.
Conclusions:
- Evidence strongly suggests that 5-HT(1A) receptor dysfunction is a potential mechanism contributing to MDD.
- This dysfunction may also underlie associated phenotypes like cognitive impairment and somatic pain.
- 5-HT(1A) receptor alterations represent a significant target for understanding and treating MDD and other stress-related disorders.
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...